Trimethoprim hydrochloride

盐酸甲氧苄啶

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTrimethoprim hydrochloride
Drug Alias Name盐酸甲氧苄氨嘧啶Primsol
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDihydrofolate reductase inhibitors
TargetsDihydrofolate reductase
Therapy Area/IndicationsOtitis MediaUrinary Tract InfectionsPneumonia, Pneumocystis
Global Approved IndicationsOtitis MediaUrinary Tract InfectionsPneumonia, Pneumocystis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date1962/01/01
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesAllegis Holdings LLC
Inactive CompaniesPangea Pharmaceuticals Llc
Active IndicationsOtitis MediaUrinary Tract InfectionsPneumonia, Pneumocystis
Inactive IndicationsN/A

Other Information

ATC CodeJ01EA01